Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation

Journal of Controlled Release

Volumn 64, Issue 1-3, 2000, Pages 27-37

  Reddy, Joseph A ^a   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Cancer gene therapy; Folate receptor endocytosis; Gene delivery; pH Sensitive lipid; Tumor targeting

Indexed keywords

CHOLESTEROL HYDROGEN SUCCINATE; CITRACONIC ANHYDRIDE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIOLEOYLPHOSPHATIDYLSERINE; DNA; FOLATE RECEPTOR; FOLIC ACID; LIPID; LIPOSOME; MACROGOL; PLASMID DNA; POLYLYSINE; RECEPTOR; UNCLASSIFIED DRUG;

CANCER CELL CULTURE; CELL NUCLEUS; CLONING VECTOR; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; DRUG FORMULATION; ENDOCYTOSIS; ENDOSOME; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROLYSIS; NONHUMAN; PH; PRIORITY JOURNAL; RECEPTOR DENSITY;

BETA-GALACTOSIDASE; CELLS, CULTURED; DNA; ENDOCYTOSIS; ETHANOLAMINES; FOLIC ACID; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; PLASMIDS; POLYLYSINE; TRANSFECTION;

EID: 0033971786     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00135-2     Document Type: Conference Paper

References (38)

1. Feldman L.J., Tahlil O., Steg G. Perspectives of arterial gene therapy for the prevention of restenosis. Cardiovasc. Res. 32:(2):1996;194-207.
2. Hargest R., Williamson R. Prophylactic gene therapy for cancer. Gene Ther. 3:(2):1996;97-102.
3. Mahato R.I., Takakura Y., Hashida M. Nonviral vectors for in vivo gene delivery - physicochemical and pharmokinetic considerations. Crit. Rev. Ther. Drug Carrier Syst. 14:(2):1997;133-172.
4. Malosky S., Kolansky D.M. Gene therapy for ischemic heart disease. Curr. Opin. Cardiol. 11:(4):1996;361-368.
5. Sandig V., Strauss M. Liver-directed gene transfer and application to therapy. J. Mol. Med. 74:(4):1996;205-212.
6. Vile R., Russell S.J. Gene transfer technologies for the gene therapy of cancer. Gene Ther. 1:(2):1994;88-98.
7. Friedmann T. Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer. 70:1992;1810-1817.
8. Culver K.W., Ram Z., Wallbridge S., Ishii H., Oldfield E.H., Blease R.M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1992;1550-1552.
9. Boyce F.M., Bucher N.L.R. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. USA. 93:(6):1996;2348-2352.
10. Gunzburg W.H., Salmons B. Development of retroviral vectors as safe, targeted gene delivery systems. J. Mol. Med. 74:(4):1996;171-182.
11. Kasahara N., Dozy A.M., Kan Y.W. Tissue-specific targeting of retroviral vectors via ligand-receptor interactions. Adv. Drug Delivery Rev. 17:(3):1995;227-234.
12. Mahato R.I., Rolland A., Tomlinson E. Cationic lipid-based gene delivery systems: pharmaceutical perspectives. Pharm Res. 14:(7):1997;853-859.
13. Gao X., Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 2:(10):1995;710-722.
14. Felgner P.L., Tsai Y.J., Sukhu L., Wheeler C.J., Manthorpe M., Marshall J., Cheng S.H. Improved cationic lipid formulations for in vivo gene therapy. Ann. NY Acad Sci. 772:1995;126-139.
15. Douglas J.T., Rogers B.E., Rosenfeld M.E., Michael S.I., Feng M.Z., Curiel D.T. Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotech. 14:(11):1996;1574-1578.
16. Lee R.J., Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271:(14):1996;8481-8487.
17. Gottschalk S., Cristiano R.J., Smith L.C., Woo S.L. Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression. Gene Ther. 1:(3):1994;185-191.
18. Leamon C.P., Pastan I., Low P.S. Cytotoxicity of folate - Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain. J. Biol. Chem. 268:(33):1993;24847-24854.
19. Leamon C.P., Low P.S. Cytotoxicity of momordin-folate conjugates in cultured human cells. J. Biol. Chem. 267:(35):1992;24966-24971.
20. Lee R.J., Low P.S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269:(5):1994;3198-3204.
21. Lee R.J., Low P.S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubucin in vitro. Biochim. Biophys. Acta. 1233:1995;134-144.
22. Wang S., Lee R.J., Cauchon G., Gorenstein D.G., Low P.S. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proc. Natl. Acad. Sci. USA. 92:(8):1995;3318-3322.
23. Leamon C.P., Low P.S. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. USA. 88:(13):1991;5572-5576.
24. Turek J.J., Leamon C.P., Low P.S. Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. J. Cell Sci. 106:(1):1993;423-430.
25. Coney L.R., Tomaselti A., Carayannopoulos L., Frasca V., Kamen B.A., Colnaghi M.I., Zurawski V.R.J. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res. 51:1991;6125-6132.
26. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski V.R.J., Kamen B.A. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52:(12):1992;3396-3401.
27. Ross J.F., Chaudhuri P.K., Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer. 73:(9):1994;2432-2443.
28. Garin-Chesa P., Campbell I., Saigo P.E., Lewis J.L.J., Old L.J., Rettig W.J. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol. 142:(2):1993;557-567.
29. Mathias C.J., Wang S., Lee R.J., Waters D.J., Low P.S., Green M.A. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of Gallium-67-Deferoxamine-folate. J. Nucl. Med. 37:(6):1996;1003-1008.
30. Mathias C.J., Wang S., Waters D.J., Turek J.J., Low P.S., Green M.A. Evaluation of 111In-DTPA-Folate as a potential folate-receptor-targeted radiopharmaceutical. J. Nucl. Med. 39:(9):1998;1579-1585.
31. Wang X., Shen F., Freisheim J.H., Gentry L.E., Ratnam M. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem. Pharm. 44:(9):1992;1898-1901.
32. Vogel K., Wang S., Lee R.J., Chmielewski J., Low P.S. Peptide-mediated release of folate-targeted liposome contents from endosomal compartments. J. Am. Chem. Soc. 118:(7):1996;1581-1586.
33. Kamata H., Yagisawa H., Takahashi S., Hirata H. Amphiphilic peptides enhance the efficiency of liposome-mediated DNA transfection. Nucleic Acids Res. 22:1994;536-537.
34. N. Duzgunes, R.M. Straubinger, P.A. Baldwin, D., Papahadjopoulus. pH-sensitive liposomes, in: Wilschut J., D., H., Eds., Membrane Fusion, Marcel Dekker, New York, 1991, pp. 713-730.
35. Drummond D.C., Daleke D.L. Synthesis and characterization of N-acylated, pH-sensitive 'caged' aminophospholipids. Chem. Phys. Lipids. 75:1995;27-41.
36. Prensky W. The radioiodination of RNA and DNA to high specific activities. Methods Cell Biol. 13:1976;121-152.
37. Rosenthal N. Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol. 152:1987;704-720.
38. Wadhwa M.S., Collard W.T., Adami R.C., McKenzie D.L., Rice K.G. Peptide-mediated gene delivery: Influence of peptide structure on gene expression. Bioconjug. Chem. 8:1997;81-88.